MAPT and Alzheimer disease: Specifically, the Reelin signaling pathway—which regulates neurodevelopment, neurogenesis, and synaptic plasticity—interacts with apolipoprotein E4, Aβ, and Tau, all of which are central to AD pathogenesis [25].